UAS LifeSciences After 30 Years of DDS Probiotics, is UP for a Change
UAS LifeSciences has introduced a completely rebranded line of probiotics called, UP4 a Happier Inside™ – Probiotics with DDS®-1.
Wausau, WI (PRWEB) February 05, 2014
The new line of probiotics, designed for easier consumer selection and specifically formulated for each individual need. Each product contains the UAS superstrain, Lactobacillus acidophilus DDS®-1 in every product. This probiotic strain has proven to be one of the best probiotics ever commercialized and is a trademarked strain of UAS LifeSciences. UAS LifeSciences is the home of some of the best probiotic scientists in the field and they have formulated a line of products that are science-based and manufactured with all of the latest probiotic technology. The result is a line of products that can withstand the rigors of manufacturing, distribution and storage and maintain their viability over 24 months. The probiotic strains used have been selected for their natural acid and bile resistance and require no special chemical coatings to get to the digestive tract alive. All products are non-dairy, gluten-free, vegan and non-GMO.
Probiotics Used by Millions – Now Even Better
Six of the products are replacements for DDS® Probiotics that have been manufactured and
marketed by UAS Laboratories since 1979. Changes have been made in all the products including more concentrated probiotics allowing the use of smaller, single-dose capsules that are easier to swallow and a total quantity increase from 50 days to 2 months’ supply.
Starting from the simplest product, DDS® Acidophilus is now UP4 Acidophilus- still containing only the probiotic superstrain, L. acidophilus DDS®-1.
DDS® Plus, the company’s most popular product, is now UP4 daily and contains 5 billion CFU per serving of L. acidophilus DDS®-1 and B. longum, great for just about every adult and still the best bargain around.
UP4 Adult replaces Probioplus DDS®, a leading product for the company, that now has an increased potency from 10 billion up to 15 billion CFU per serving of L. acidophilus DDS®-1, B. lactis, B. longum and B. bifidum.
UP4 Junior replaces DDS® Junior and maintains the same tested formula of B. lactis and L. acidophilus DDS®-1 in easy-to-use powder formulated for infants and young children.
UP4 Green replaces ProbioGreen and contains high quality organic Spirulina and the adult formula probiotic (L. acidophilus DDS®-1, B. longum, B. lactis and B. bifidum) still a great formula to help healthy aging.
UP4 Women’s, replaces Cran-Gyn DDS® and has been reformulated to contain the Lactobacilli found in a healthy vaginal tract – L. rhamnosus, L. plantarum, L. gasseri along with L. acidophilus DDS®-1 and B. lactis – all at higher potency of 10 billion CFU per serving. Equally important, UP4 Women’s contains certified organic cranberry containing 36 mg (the efficacious dose) of proanthocyanidins, the active portion of cranberry, to help maintain a healthy urinary tract.
In addition, there are three exciting new products in the line – KIDS CUBES, UP4 Senior and UP4 Ultra to fill the needs of all consumers.
New Products in Distribution – Hitting the Shelves Now
These products have already been ordered by all major distributors in the Natural Product Industry and will be hitting the shelves in February with expected full consumer launch by April.
About UAS LifeSciences
Founded in 1979, UAS LifeSciences has delivered the highest quality, science-backed probiotics to the natural products marketplace for more than thirty years. Strictly dedicated to probiotic based supplements, UAS is committed to designing innovative and effective formulations based on L. acidophilus DDS®-1, a strain that has been researched and tested rigorously for decades. UAS LifeSciences’ products are sold to natural products retailers and health professionals in the U.S. and Canada. The company is fully integrated from formulation through manufacturing, packaging and marketing, and adheres to the highest quality standards. UAS has recently made significant investments in research, streamlining operations through new technology and innovations, and ultimately introducing state-of-the-art products.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/02/prweb11552820.htm